It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2015.
2015 | Bangalore, Karnataka, India | ActiveIodine India Pharmaceuticals Private Limited, a active private limited company, was established on 27 May 2015 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24297KA2015PTC080569. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Its leadership includes Vrushabendra Swamy Bhyrapurmathad (Additional Director), Gopkumar Prabhakar Acharya (Director), Sridevi (Director). Past directors included Rajesh Jain. It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at No 121/21,Kumbalagodu Industrial Area,1St Phase, Bangalore, Karnataka, 560074.
U24297KA2015PTC080569
080569
27 May 2015
₹2.50 M
₹2.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Iodine India Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vrushabendra Swamy Bhyrapurmathad | Additional Director | 22 Mar 2016 | Current |
| Gopkumar Prabhakar Acharya | Director | 27 May 2015 | Current |
| Sridevi | Director | 27 May 2015 | Current |
| Rajesh Jain | Additional Director | 22 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Iodine India Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 74.59% increase. The company also saw a substantial improvement in profitability, with a 88.52% increase in profit. The company's net worth dipped by a decrease of 4.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Iodine India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2015 | State Bank Of Mysore | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Iodine India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Iodine India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iodine India Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Iodine India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Progress on Iodine India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore. was documented.
The activity Vrushabendra Swamy Bhyrapurmathad was appointed as a Additional Director was appointed as a Additional Director on 22 Mar 2016 & has been associated with this company since 9 years 8 months . was completed.
The activity Rajesh Jain was appointed as a Additional Director was appointed as a Additional Director on 22 Mar 2016 & has been associated with this company since 9 years 8 months . was completed.
A charge with State Bank Of Mysore amounted to Rs. 5.00 M with Charge ID 10600701 was registered on 16 Oct 2015. was recorded as a recent event.
The activity Gopkumar Prabhakar Acharya was appointed as a Director was appointed as a Director on 27 May 2015 & has been associated with this company since 10 years 6 months . was completed.
The CIN of Iodine India Pharmaceuticals Private Limited is U24297KA2015PTC080569.
Iodine India Pharmaceuticals Private Limited is headquartered at No 121/21,Kumbalagodu Industrial Area,1St Phase, Bangalore, Karnataka, 560074.
Iodine India Pharmaceuticals Private Limited was incorporated on 27 May 2015.
The current directors of Iodine India Pharmaceuticals Private Limited are
The primary industry of Iodine India Pharmaceuticals Private Limited is Manufacturing.
Iodine India Pharmaceuticals Private Limited is unlisted.
The authorized capital of Iodine India Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.
The compliance status of Iodine India Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX